SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Volquardsen who wrote (610)9/12/1997 1:35:00 PM
From: luis a. garcia   of 1115
 
Henry James probably does know something, however on the one hand he is generalizing. and on the other hand he is discounting the previous trial which demonstrated Lidakol effectiveness in both placebo form i.e. low grade worst batch medicine. and best case as a medicine. The FDA has been totally working with lidak for over two maybe three years on this issue. And that counts for something. At one time they asked Lidak to show Lidakol was not a carcinogen... then Lidak showed the FDA sufficient evidence so they would drop that demand. Its in the record.
The climate at FDA has changed a lot and James is citing the past...
He is projecting from his past experience and that is all... The trade lies in defying the conventional wisdom and getting in when James i.e. conventional wisdom types are skeptic. We have the added advantage that a very savvy person like Bud favors the play. But the market is the market and when will the stock be recognized? probably as soon as the NDA is filed in 97..and approved in 98.

luis
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext